Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings.

Andrei Saraiva PuryskoCristina Magi-GalluzziOmar Y MianSarah SittenfeldElai DavicioniMarguerite du PlessisChristine BuerkiJennifer BullenLin LiAnant MadabhushiAndrew StephensonEric A Klein

Published in: European radiology (2019)

• MRI phenotypes of prostate cancer as defined by PI-RADS v2 positively correlated with a genomic classifier that estimates the risk of early metastases. • Most but not all MRI-invisible lesions had a low risk for early metastases according to the genomic classifier. • MRI could be used in conjunction with genomic assays to identify lesions that may carry biological potential for early metastases.

Keyphrases

prostate cancer
contrast enhanced
magnetic resonance imaging
copy number
diffusion weighted imaging
radical prostatectomy
computed tomography
magnetic resonance
high throughput
dna methylation
single cell